JPRN-UMIN000036845
Completed
未知
Phase I/II clinical trial of image-guided 3 dimensional beam-convergent and extremely hypofractionated radiotherapy for patients with cervical cancer unsuitable for intracavitary brachytherapy - Phase I/II clinical trial of image-guided 3 dimensional beam-convergent and extremely hypofractionated RT for patients with cervical cancer unsuitable for ICBT
Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital0 sites21 target enrollmentJuly 1, 2019
Conditionsterine cervical cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- terine cervical cancer
- Sponsor
- Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital
- Enrollment
- 21
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Serious medical or psychological problems 2\. Other active cancer within 3 years 3\. Be pregnant or just after giving birth
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
A clinical trial to compare toxicity reduction between image guided intensity modulated radiotherapy (IG-IMRT) and conventional radiotherapy in Cancer Cervix (PARCER) patients.Health Condition 1: null- Cervical cancerCTRI/2012/12/003249Tata Memorial Centre240
Completed
Not Applicable
Clinical trial to evaluate 3D-printed denturesPreference for type of denturesOral HealthISRCTN17073439niversity of Leeds18
Not yet recruiting
Phase 3
Radiation therapy with Image Guided Intensity Modulated Radiotherapy and standard radiation therapy after surgery in cervical cancer patients.CTRI/2010/091/002959il240
Active, not recruiting
Phase 1
An Imaging Sub-Study of the Phase III Randomized, Placebo-Controlled Clinical Trial to Assess the Safety and Efficacy of Odanacatib (MK-0822) to Reduce the Risk of Fracture in Osteoporotic Postmenopausal Women Treated With Vitamin D and Calcium - The Imaging Sub-study for the Fracture TrialPostmenopausal OsteoporosisMedDRA version: 9.1Level: LLTClassification code 10017082Term: Fracture due to osteoporosisMedDRA version: 9.1Level: LLTClassification code 10031285Term: Osteoporosis postmenopausalEUCTR2008-004578-42-DKMerck & Co. Inc.400
Active, not recruiting
Phase 1
An Imaging Sub-Study of the Phase III Randomized, Placebo-Controlled Clinical Trial to Assess the Safety and Efficacy of Odanacatib (MK-0822) to Reduce the Risk of Fracture in Osteoporotic Postmenopausal Women Treated With Vitamin D and Calcium - The Imaging Sub-study for the Fracture TrialEUCTR2008-004578-42-CZMerck & Co., Inc.164